Rodney S, Boneh A
Imperial College School of Medicine, London, UK.
Metabolic Genetics, Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Flemington Road, Victoria, Melbourne, 3052, Australia.
JIMD Rep. 2013;9:97-104. doi: 10.1007/8904_2012_186. Epub 2012 Oct 30.
Urea cycle disorders (UCDs) result from inherited defects in the ammonia detoxification pathway, leading to episodes of hyperammonaemia and encephalopathy. The purpose of this study was to answer the question, "what is the likely plasma amino acid profile of a patient known to have a UCD presenting with hyperammonaemia during acute metabolic decompensation", in order to support informed decisions regarding management.We analysed the results of plasma ammonia levels and amino acid profiles taken simultaneously or within 30 min of each other during acute admissions of all patients with a UCD at the Royal Children's Hospital, Melbourne, over 28 years. Samples from 96 admissions (79, 9 and 8 admissions for OTC, CPS and ASS deficiencies, respectively) from 14 patients fulfilled these criteria. Amino acid levels were measured by ion exchange chromatography with post-column ninhydrin derivatisation and interpreted in relation to age-related reference ranges.Plasma concentrations of all measured essential amino acids were low or low-normal in almost all samples. There was a strong positive correlation between low plasma branched-chain amino acids and other essential amino acids, and a negative correlation between ammonia and phenylalanine to tyrosine (Phe:Tyr) ratio in patients with OTC deficiency, and between glutamine and Phe:Tyr ratio in all patients, indicating protein deficiency.
At admission, protein deficiency is common in patients with a UCD with hyperammonaemia. These results challenge the current guideline of stopping protein intake during acute decompensation in UCDs. Supplementation with essential amino acids (particularly branched-chain amino acids) at these times should be considered.
尿素循环障碍(UCDs)由氨解毒途径中的遗传缺陷引起,导致高氨血症和脑病发作。本研究的目的是回答“已知患有UCD的患者在急性代谢失代偿期间出现高氨血症时,其血浆氨基酸谱可能是怎样的”这一问题,以支持有关管理的明智决策。我们分析了墨尔本皇家儿童医院28年间所有UCD患者急性入院期间同时采集或在彼此30分钟内采集的血浆氨水平和氨基酸谱结果。14名患者的96份入院样本(分别有79、9和8份入院样本为鸟氨酸氨甲酰基转移酶(OTC)、氨甲酰磷酸合成酶(CPS)和精氨酸琥珀酸合成酶(ASS)缺乏症)符合这些标准。氨基酸水平通过柱后茚三酮衍生化的离子交换色谱法测量,并根据年龄相关参考范围进行解释。几乎所有样本中所有测量的必需氨基酸的血浆浓度都较低或处于低正常水平。血浆支链氨基酸水平低与其他必需氨基酸之间存在强正相关,在OTC缺乏症患者中,氨与苯丙氨酸与酪氨酸(Phe:Tyr)比值之间存在负相关,在所有患者中谷氨酰胺与Phe:Tyr比值之间存在负相关,表明存在蛋白质缺乏。
入院时,患有高氨血症的UCD患者普遍存在蛋白质缺乏。这些结果对目前UCD急性失代偿期间停止蛋白质摄入的指南提出了挑战。此时应考虑补充必需氨基酸(尤其是支链氨基酸)。